SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.81-4.2%Dec 5 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (9592)4/11/1999 5:59:00 PM
From: Robert K.  Read Replies (1) of 17367
 
And what inhibits PMNL response, which contributes to vascular damage and multiorgan failure?
This does not prove anything but its a hopeful sign IMO.
(hopefully thats a major understatement)
ncbi.nlm.nih.gov

So in summary we have this article in may, the toxoplasmosis artcile in april, the baboon article in march. Hmmmmmm. All well read journals.
Oh yeah, remember Heyderman is from a choice location in the UK. Double Hmmmm.
Standard K.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News